192 related articles for article (PubMed ID: 1666685)
1. The neurobiology of neurotensin: focus on neurotensin-dopamine interactions.
Kasckow J; Nemeroff CB
Regul Pept; 1991 Oct; 36(2):153-64. PubMed ID: 1666685
[TBL] [Abstract][Full Text] [Related]
2. Interactions of neurotensin with dopamine-containing neurons in the central nervous system.
Ervin GN; Nemeroff CB
Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12 Suppl():S53-69. PubMed ID: 3074341
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin and dopamine interactions.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Pharmacol Rev; 2001 Dec; 53(4):453-86. PubMed ID: 11734615
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin-dopamine interactions: relevance to schizophrenia and the action of antipsychotic drugs.
Stowe ZN; Bissette G; Nemeroff CB
Yakubutsu Seishin Kodo; 1991 Feb; 11(1):49-59. PubMed ID: 1679273
[TBL] [Abstract][Full Text] [Related]
5. Bioactive analogs of neurotensin: focus on CNS effects.
Boules M; Fredrickson P; Richelson E
Peptides; 2006 Oct; 27(10):2523-33. PubMed ID: 16882457
[TBL] [Abstract][Full Text] [Related]
6. Central neurotensin inhibits gastric acid secretion: an adrenergic mechanism in rats.
Zhang L; Xing LP; Demers L; Washington J; Kauffman GL
Gastroenterology; 1989 Nov; 97(5):1130-4. PubMed ID: 2551763
[TBL] [Abstract][Full Text] [Related]
7. The effects of typical and atypical antipsychotic drugs on neurotensin-containing neurons in the central nervous system.
Kinkead B; Nemeroff CB
J Clin Psychiatry; 1994 Sep; 55 Suppl B():30-2. PubMed ID: 7961568
[TBL] [Abstract][Full Text] [Related]
8. The role of neurotensin in the pathophysiology of schizophrenia and the mechanism of action of antipsychotic drugs.
Binder EB; Kinkead B; Owens MJ; Nemeroff CB
Biol Psychiatry; 2001 Dec; 50(11):856-72. PubMed ID: 11743941
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
Singh NA; Bush LG; Gibb JW; Hanson GR
Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
[TBL] [Abstract][Full Text] [Related]
10. Neurotensin, schizophrenia, and antipsychotic drug action.
Kinkead B; Nemeroff CB
Int Rev Neurobiol; 2004; 59():327-49. PubMed ID: 15006494
[TBL] [Abstract][Full Text] [Related]
11. The electrophysiological actions of neurotensin in the central nervous system.
Stowe ZN; Nemeroff CB
Life Sci; 1991; 49(14):987-1002. PubMed ID: 1890928
[TBL] [Abstract][Full Text] [Related]
12. Do neurotensin receptor agonists represent a novel class of antipsychotic drugs?
Cáceda R; Kinkead B; Nemeroff CB
Semin Clin Neuropsychiatry; 2003 Apr; 8(2):94-108. PubMed ID: 12728409
[TBL] [Abstract][Full Text] [Related]
13. [Neurotensin/dopamine interactions].
Kitabgi P; Hervé D; Studler JM; Tramu G; Rostène W; Tassin JP
Encephale; 1989; 15 Spec No():91-4. PubMed ID: 2545433
[No Abstract] [Full Text] [Related]
14. Anatomy and mechanisms of neurotensin-dopamine interactions in the central nervous system.
Lambert PD; Gross R; Nemeroff CB; Kilts CD
Ann N Y Acad Sci; 1995 May; 757():377-89. PubMed ID: 7611695
[No Abstract] [Full Text] [Related]
15. Neurotensin: role in psychiatric and neurological diseases.
Cáceda R; Kinkead B; Nemeroff CB
Peptides; 2006 Oct; 27(10):2385-404. PubMed ID: 16891042
[TBL] [Abstract][Full Text] [Related]
16. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
17. Neurotensin levels and receptors in HAS and LAS rat brains: effects of ethanol.
Erwin VG; Draski LJ; Deitrich RA
Pharmacol Biochem Behav; 1996 Jun; 54(2):525-32. PubMed ID: 8743618
[TBL] [Abstract][Full Text] [Related]
18. Sigma receptor "antagonist" BMY 14802 increases neurotensin concentrations in the rat nucleus accumbens and caudate.
Levant B; Nemeroff CB
J Pharmacol Exp Ther; 1990 Jul; 254(1):330-5. PubMed ID: 1973198
[TBL] [Abstract][Full Text] [Related]
19. Neurotensin and the mesocorticolimbic dopamine system.
Bissette G; Nemeroff CB
Ann N Y Acad Sci; 1988; 537():397-404. PubMed ID: 2849357
[No Abstract] [Full Text] [Related]
20. Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.
Quirion R; Chiueh CC; Everist HD; Pert A
Brain Res; 1985 Feb; 327(1-2):385-9. PubMed ID: 2985182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
